Q BioMed Inc (QBIO)
0.00
USD |
OTCM |
Dec 03, 16:00
Q BioMed Max Drawdown (5Y): 100.0% for Nov. 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| November 30, 2024 | 100.0% |
| October 31, 2024 | 100.0% |
| September 30, 2024 | 100.0% |
| August 31, 2024 | 100.0% |
| July 31, 2024 | 100.0% |
| June 30, 2024 | 100.0% |
| May 31, 2024 | 100.0% |
| April 30, 2024 | 100.0% |
| March 31, 2024 | 100.0% |
| February 29, 2024 | 100.0% |
| January 31, 2024 | 100.0% |
| December 31, 2023 | 100.0% |
| November 30, 2023 | 100.0% |
| October 31, 2023 | 99.99% |
| September 30, 2023 | 99.99% |
| August 31, 2023 | 99.99% |
| July 31, 2023 | 99.99% |
| June 30, 2023 | 99.99% |
| May 31, 2023 | 99.86% |
| April 30, 2023 | 99.86% |
| March 31, 2023 | 99.86% |
| February 28, 2023 | 99.86% |
| January 31, 2023 | 99.82% |
| December 31, 2022 | 99.78% |
| November 30, 2022 | 99.78% |
| Date | Value |
|---|---|
| October 31, 2022 | 99.77% |
| September 30, 2022 | 99.70% |
| August 31, 2022 | 99.50% |
| July 31, 2022 | 99.32% |
| June 30, 2022 | 99.13% |
| May 31, 2022 | 98.46% |
| April 30, 2022 | 97.94% |
| March 31, 2022 | 96.82% |
| February 28, 2022 | 96.69% |
| January 31, 2022 | 96.69% |
| December 31, 2021 | 96.69% |
| November 30, 2021 | 96.50% |
| October 31, 2021 | 96.50% |
| September 30, 2021 | 96.50% |
| August 31, 2021 | 96.50% |
| July 31, 2021 | 96.50% |
| June 30, 2021 | 96.50% |
| May 31, 2021 | 96.50% |
| April 30, 2021 | 96.50% |
| March 31, 2021 | 96.50% |
| February 28, 2021 | 96.50% |
| January 31, 2021 | 96.50% |
| December 31, 2020 | 96.50% |
| November 30, 2020 | 96.50% |
| October 31, 2020 | 96.50% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
96.50%
Minimum
Dec 2019
100.0%
Maximum
Nov 2023
98.26%
Average
98.79%
Median
Max Drawdown (5Y) Benchmarks
| VBI Vaccines Inc | 100.00% |
| Cantabio Pharmaceuticals Inc | 99.99% |
| Calithera Biosciences Inc | 100.00% |
| Affymax Inc | 99.91% |
| Scopus BioPharma Inc | -- |